Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Diabetes Devices Market Analysis 2016-2026: Covering Sinocare, Sanofi & Novo Nordisk Among Others - ResearchAndMarkets.com

February 5, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Feb 5, 2020--

The “Global Diabetes Devices Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering.

The Global Diabetes Devices market is expected to reach $44.66 billion by 2026 growing at a CAGR of 9.3% from 2018 to 2026.

Some of the factors such as rising awareness about therapeutics for diabetes & diabetes management among patients and the growing intensity of obesity and technological progressions are fuelling the market growth. However, rising advancement of non-invasive insulin delivery methods is restraining market growth.

Key Questions Answered in this Report:

Based on the type, monitoring devices segment has witnessed significant growth due to the rapid adoption of these user-friendly, quick, and accurate devices by patients for homecare use. Increasing awareness regarding diabetes, along with availability of a wide range of devices with fast and precise outcomes, is anticipated to fuel the segment.

Key Topics Covered:

1 Market Synopsis

2 Research Outline

2.1 Research Snapshot

2.2 Research Methodology

2.3 Research Sources

2.3.1 Primary Research Sources

2.3.2 Secondary Research Sources

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Diabetes Devices Market, By Type

5.1 Introduction

5.2 Monitoring and Diagnostic Devices

5.3 Insulin Delivery Devices

6 Global Diabetes Devices Market, By Distribution Channels

6.1 Introduction

6.2 Retail Pharmacies

6.3 Online Pharmacies

6.4 Hospital Pharmacies

6.5 Home Care

6.6 Diabetes Clinics/ Centers

6.7 Ambulatory Surgery Centers

6.8 Other Distribution Channels

7 Global Diabetes Devices Market, By Geography

7.1 Introduction

7.2 North America

7.3 Europe

7.4 Asia Pacific

7.5 South America

7.6 Middle East & Africa

8 Strategic Benchmarking

9 Vendors Landscape

9.1 Sinocare, Inc.

9.2 Sanofi

9.3 Novo Nordisk

9.4 Medtronic PLC

9.5 Johnson & Johnson (LifeScan, Inc.)

9.6 F. Hoffmann-La Roche Ag

9.7 Eli Lilly and Company

9.8 DexCom Inc.

9.9 Bayer Corporation

9.10 Arkray, Inc.

9.11 Abbott Laboratories

For more information about this report visit https://www.researchandmarkets.com/r/timqw1

View source version on businesswire.com:https://www.businesswire.com/news/home/20200205005649/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 02/05/2020 12:21 PM/DISC: 02/05/2020 12:21 PM